<DOC>
	<DOCNO>NCT00114374</DOCNO>
	<brief_summary>The purpose study examine efficacy escitalopram compare placebo reduce Acute Stress Disorder ( ASD ) symptoms prevent emergence Post-Traumatic Stress Disorder ( PTSD ) patient medical trauma risk development PTSD base presence ASD symptom .</brief_summary>
	<brief_title>SSRI Administration Reduce Acute Stress Disorder Symptoms Prevent Depression PTSD Physical Trauma Victims</brief_title>
	<detailed_description>Posttraumatic Stress Disorder ( PTSD ) relatively common , distress disable condition may occur trauma related event include injury . The emergence Acute Stress Disorder shortly trauma appear strong predictor later develop PTSD ( Brewin et al. , 1999 ) . Although SSRIs commonly administer general medical practice demonstrate effective treatment PTSD , systematic study use treatment ASD , ASD symptom , prevention PTSD , study represent one first attempt systematically evaluate use indication . Sixty study participant ( 30 randomize ) drawn patient admit Massachusetts General Hospital medical/surgical inpatient unit traumatic injury occur prior 3 week . Study participant must meet criterion A1 , A2 least one additional category Acute Stress Disorder symptom ( i.e. , B , C D criterion ) , determine Acute Stress Disorder Interview upon initial evaluation , qualify randomization 12 week , double-blind flexible-dose treatment trial escitalopram ( 10-40 mg/d ) versus placebo .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Traumatic , Acute</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Male female outpatient least 18 year age primary ( condition central patient 's current distress ) symptom Acute Stress Disorder define DSMIV criterion : A1 , A2 least one additional category Acute Stress Disorder symptom ( i.e. , B , C D criterion ) . Patients must medical trauma ( even fully resolve minor ) within prior 3 week result admission emergency room and/or inpatient hospital part acute trauma result ASD symptom . Patients exclude entry study current serious medical instability hemodynamic compromise , serious head injury result impaired mental status . Patients history medical instability associate traumatic injury allow study entry problem resolve ( long resolve within 3 week trauma per inclusion criterion ) . Patients trauma result head injury related seizure , epilepsy ( except prior history febrile seizure infancy exclusionary ) . Pregnant lactate woman childbearing potential use medically accept form contraception exclude . Concurrent use antidepressant , exception trazodone &lt; 100mg/day sleep , amitriptyline dos â‰¤ 50 mg daily pain . Patients may remain concomitant benzodiazepine ( &lt; 2 mg/d clonazepam equivalent ) , sleep aid ( i.e. , trazodone , zolpidem ( Ambien ) , zaleplon ( Sonata ) ) long drug therapy initiate 1 week prior randomization ; dose hold constant study , control analysis . Lifetime diagnosis schizophrenia psychosis , mental retardation , organic mental disorder , bipolar disorder ; obsessivecompulsive disorder , eat disorder , cut significant selfinjurious behavior , alcohol/substance abuse disorder within last 3 month study exclusion . Patients current primary diagnosis major depression , dysthymia , social anxiety disorder , panic disorder , generalize anxiety disorder exclude ; thus , presence disorder permissible long ASD symptom constitute predominant symptomatology . Patients history hypersensitivity prior poor response escitalopram exclude . Concurrent dynamic supportive psychotherapy permit long ongoing least 1 month prior onset study entry . Patients positive toxicology screen baseline consistent evidence current substance abuse dependence determine clinical interview .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Acute Stress Disorder</keyword>
	<keyword>Posttraumatic Stress Disorder</keyword>
	<keyword>Escitalopram</keyword>
	<keyword>Double-Blind</keyword>
</DOC>